We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$809M
AUM Growth
-$221M
Cap. Flow
-$234M
Cap. Flow %
-28.88%
Top 10 Hldgs %
38.79%
Holding
5,677
New
1,365
Increased
1,774
Reduced
1,410
Closed
1,002

Sector Composition

Rank Sector Weight
1 Financials 4.61%
2 Consumer Discretionary 4.23%
3 Healthcare 3.96%
4 Technology 3.11%
5 Energy 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVDY
2601
DELISTED
Everyday Health, Inc.
EVDY
$13K ﹤0.01%
986
-1,103
-53% -$15.1K
LDRH
2602
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$13K ﹤0.01%
365
-190
-34% -$6.89K
HFFC
2603
DELISTED
H F FINL CORP
HFFC
$13K ﹤0.01%
910
+385
+73% +$5.6K
LABC
2604
DELISTED
LOUISIANA BANCORP INC COM STK NEW (LA)
LABC
$13K ﹤0.01%
602
+251
+72% +$5.37K
EMEY
2605
DELISTED
ISHARES MSCI EMERGING MKTS ENERGY CAPPED ETF
EMEY
$13K ﹤0.01%
481
-600
-56% -$16.7K
CIZN
2606
DELISTED
Citizens Holding Co.
CIZN
$13K ﹤0.01%
711
+149
+27% +$2.79K
CSBK
2607
DELISTED
Clifton Bancorp Inc.
CSBK
$13K ﹤0.01%
+911
New +$12.3K
SPAN
2608
DELISTED
Span-America Medical Systems I
SPAN
$13K ﹤0.01%
649
-8
-1% -$145
GAF
2609
DELISTED
SPDR S&P Emerging Middle East & Africa ETF
GAF
$13K ﹤0.01%
187
+51
+38% +$3.52K
RPRX
2610
DELISTED
Repros Therapeutics Inc.
RPRX
$13K ﹤0.01%
1,561
+1,192
+323% +$10.7K
AV
2611
DELISTED
Aviva Plc
AV
$13K ﹤0.01%
814
+553
+212% +$8.98K
AADR icon
2612
AdvisorShares Dorsey Wright ADR ETF
AADR
$38.8M
$12K ﹤0.01%
+300
New +$11.4K
AVT icon
2613
Avnet
AVT
$7.96B
$12K ﹤0.01%
277
-30
-10% -$1.32K
CATX icon
2614
Perspective Therapeutics
CATX
$338M
$12K ﹤0.01%
738
+408
+124% +$6.06K
CBT icon
2615
Cabot Corp
CBT
$4.52B
$12K ﹤0.01%
279
-1,921
-87% -$84.9K
CCLD icon
2616
CareCloud
CCLD
$105M
$12K ﹤0.01%
5,518
+1,613
+41% +$4.11K
CCRN
2617
DELISTED
Cross Country Healthcare
CCRN
$12K ﹤0.01%
+997
New +$11.4K
CENTA icon
2618
Central Garden & Pet Co Class A
CENTA
$2.39B
$12K ﹤0.01%
1,399
+34
+2% +$273
CG icon
2619
Carlyle Group
CG
$17.2B
$12K ﹤0.01%
+451
New +$12K
CMTL icon
2620
Comtech Telecommunications
CMTL
$52.1M
$12K ﹤0.01%
421
+395
+1,519% +$12.9K
CYBR
2621
DELISTED
CyberArk
CYBR
$12K ﹤0.01%
+209
New +$9.86K
DAC icon
2622
Danaos Corp
DAC
$2.55B
$12K ﹤0.01%
+126
New +$10.1K
DLNG icon
2623
Dynagas LNG Partners
DLNG
$137M
$12K ﹤0.01%
600
+497
+483% +$9.25K
EBMT icon
2624
Eagle Bancorp Montana
EBMT
$185M
$12K ﹤0.01%
+1,103
New +$12.1K
FF icon
2625
Future Fuel
FF
$230M
$12K ﹤0.01%
1,172
-254
-18% -$3.03K

Similar funds

Tower Research Capital (TRC)'s Q1 2015 Portfolio in Review

As of Q1 2015, Tower Research Capital (TRC) held 5,677 positions worth $809M, down 21% from $1.03B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Tower Research Capital (TRC) withdrew a net $234M in Q1 2015, closing 1,002 positions and reducing 1,410 holdings. Its most notable exit was iShares Core S&P Mid-Cap ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 1.9% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in VanEck Semiconductor ETF worth $24.6M.

  • Tower Research Capital (TRC)'s largest Q1 2015 buy was VanEck Semiconductor ETF: 889,360 shares worth $24.6M.
  • Tower Research Capital (TRC) added most to VanEck Gold Miners ETF in Q1 2015, an estimated $21.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $252M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2015, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 39% of its $809M portfolio in Q1 2015.
  • Tower Research Capital (TRC) opened 1,365 new positions and closed 1,002 in Q1 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 21% quarter-over-quarter to $809M.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2015, filed 12 May 2015.